A cancer gene therapy approach through translational control of a suicide gene
- 27 May 2002
- journal article
- Published by Springer Science and Business Media LLC in Cancer Gene Therapy
- Vol. 9 (6), 505-512
- https://doi.org/10.1038/sj.cgt.7700469
Abstract
No abstract availableKeywords
This publication has 15 references indexed in Scilit:
- Cancer gene therapy: fringe or cutting edge?Nature Reviews Cancer, 2001
- Eukaryotic initiation factor-4E in superficial and muscle invasive bladder cancer and its correlation with vascular endothelial growth factor expression and tumour progressionBritish Journal of Cancer, 2000
- Upregulation of protein synthesis initiation factor eIF-4E is an early event during colon carcinogenesisOncogene, 1999
- Cooperative therapeutic effects of androgen ablation and adenovirus-mediated herpes simplex virus thymidine kinase gene and ganciclovir therapy in experimental prostate cancerCancer Gene Therapy, 1999
- Detection of the proto-oncogene eIF4E in surgical margins may predict recurrence in head and neck cancerOncogene, 1997
- Translational regulation of vascular permeability factor by eukaryotic initiation factor 4E: Implications for tumor angiogenesisInternational Journal of Cancer, 1996
- The proto‐oncogene/translation factor eIF4E: A survey of its expression in breast carcinomasInternational Journal of Cancer, 1995
- Therapeutic agents for treatment of established metastases and inhibitors of metastatic spreadCurrent Opinion in Oncology, 1992
- Multidrug resistance in human cancerCritical Reviews in Oncology/Hematology, 1992
- Problems Posed for Cancer Treatment by Tumor Cell HeterogeneityPublished by Springer Science and Business Media LLC ,1986